Dr. Okechukwu Anyanwu is the Group Chairman of DCL Group, a leading indigenous clinical laboratory solutions provider in West Africa. A Medical Laboratory Scientist, entrepreneur, and business leader with over 20 years of experience in Nigeria and Europe, he founded DCL Laboratory Products Ltd in 2005 to modernize laboratory practice through advanced diagnostic technologies.

He pioneered the introduction of automated laboratory systems, apheresis technology, and immunohistochemistry robotics in Nigeria, while supporting major healthcare milestones such as successful bone marrow transplantation at UBTH. Renowned for his commitment to patient safety and capacity building, he has received numerous awards for advancing laboratory healthcare across West Africa.

1. Briefly tell us about your organisation, the journey to date and your focus areas.

DCL Is a leading indigenous healthcare and clinical laboratory solutions provider in West Africa, committed to improving healthcare delivery through innovative medical technologies, laboratory automation, diagnostics, and healthcare support services. Established in 2005, DCL began as a bridge between global manufacturers of medical laboratory equipment and healthcare institutions in Nigeria. Over the years, the company has expanded its footprint across West Africa with regional operations in Gambia, Ghana, Liberia, and Sierra Leone.
Our journey has been defined by pioneering achievements in laboratory automation, transfusion medicine, molecular diagnostics, histopathology, and healthcare capacity building. DCL has consistently introduced cutting-edge technologies into the region, supported healthcare institutions with training and technical expertise, and contributed significantly to improving diagnostic accuracy and patient outcomes.
Our focus areas include clinical laboratory solutions, diagnostic equipment, healthcare technology integration, medical training, after-sales support, healthcare infrastructure solutions, and strategic partnerships that strengthen healthcare systems across Africa.

2. WHX Lagos is a one-stop destination for the region’s booming healthcare industry. Give us an insight into what your organisation is bringing to the show and the opportunities in the store for visitors to the event.

At WHX Lagos, DCL Group will showcase a broad range of innovative healthcare and diagnostic solutions designed to improve efficiency, accuracy, and patient care across healthcare facilities in Africa. Visitors can expect to experience advanced laboratory technologies, automation systems, diagnostic analyzers, transfusion medicine solutions, pathology innovations, and integrated healthcare support services from globally recognized manufacturers represented by DCL.
The exhibition will provide healthcare professionals, laboratory scientists, hospital administrators, policymakers, and investors with opportunities to engage directly with our experts, explore emerging technologies, and gain practical insights into modern laboratory and healthcare management solutions. We will also highlight our technical support capabilities, training programs, and partnership opportunities aimed at strengthening healthcare systems in the region.
WHX Lagos presents an excellent platform for collaboration, networking, knowledge exchange, and discovering scalable solutions that address the evolving healthcare needs of Africa.

3. What are your organisational goals for 2026-2027? Please highlight some of your recent and upcoming partnerships, if any.

For 2026–2027, DCL Group’s strategic goals are centered on expanding access to quality healthcare technologies, deepening laboratory automation across Africa, strengthening healthcare infrastructure, and advancing digital and integrated diagnostic solutions. We are focused on increasing our regional presence, enhancing customer support systems, investing in capacity development for healthcare professionals, and introducing more innovative technologies that improve diagnostic turnaround time and patient outcomes.
Another major goal is to deepen collaborations with government institutions, teaching hospitals, private healthcare providers, and international healthcare technology manufacturers to drive sustainable healthcare transformation across the region.
DCL continues to maintain strategic partnerships with several globally recognized healthcare and diagnostic manufacturers, enabling us to deliver world-class laboratory and medical solutions to healthcare institutions in West Africa. We are also actively expanding partnerships focused on healthcare innovation, laboratory modernization, training, and disease surveillance initiatives aimed at improving healthcare delivery standards across the continent.